MDTMedtronic plc

NYSE medtronic.com


$ 89.24 $ -1.07 (-1.18 %)    

Thursday, 12-Sep-2024 10:41:57 EDT
QQQ $ 469.65 $ 1.02 (0.22 %)
DIA $ 408.89 $ -0.57 (-0.14 %)
SPY $ 555.20 $ 0.21 (0.04 %)
TLT $ 100.03 $ -0.34 (-0.34 %)
GLD $ 235.57 $ 0.93 (0.4 %)
$ 90.35
$ 90.31
$ 73.58 x 160
$ 89.26 x 200
$ 90.32 - $ 90.47
$ 67.11 - $ 91.49
5,805,980
na
115.87B
$ 0.93
$ 29.51
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-27-2024 07-26-2024 10-Q
2 06-20-2024 04-26-2024 10-K
3 02-27-2024 01-26-2024 10-Q
4 11-30-2023 10-27-2023 10-Q
5 08-31-2023 07-28-2023 10-Q
6 06-22-2023 04-28-2023 10-K
7 03-01-2023 01-27-2023 10-Q
8 12-01-2022 10-28-2022 10-Q
9 09-01-2022 07-29-2022 10-Q
10 06-23-2022 04-29-2022 10-K
11 03-03-2022 01-28-2022 10-Q
12 12-02-2021 10-29-2021 10-Q
13 09-02-2021 07-30-2021 10-Q
14 06-25-2021 04-30-2021 10-K
15 03-05-2021 01-29-2021 10-Q
16 12-03-2020 10-30-2020 10-Q
17 09-03-2020 07-31-2020 10-Q
18 06-19-2020 04-24-2020 10-K
19 02-28-2020 01-24-2020 10-Q
20 12-03-2019 10-25-2019 10-Q
21 08-30-2019 07-26-2019 10-Q
22 06-21-2019 04-26-2019 10-K
23 03-01-2019 01-25-2019 10-Q
24 11-29-2018 10-26-2018 10-Q
25 08-31-2018 07-27-2018 10-Q
26 06-22-2018 04-27-2018 10-K
27 03-02-2018 01-26-2018 10-Q
28 12-04-2017 10-27-2017 10-Q
29 09-01-2017 07-28-2017 10-Q
30 06-27-2017 04-28-2017 10-K
31 03-03-2017 01-27-2017 10-Q
32 12-05-2016 10-28-2016 10-Q
33 09-07-2016 07-29-2016 10-Q
34 06-28-2016 04-29-2016 10-K
35 03-09-2016 01-29-2016 10-Q
36 12-09-2015 10-30-2015 10-Q
37 09-09-2015 07-31-2015 10-Q
38 06-23-2015 04-24-2015 10-K
39 02-27-2015 01-23-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 3m-visa-medtronic-and-more-on-cnbcs-final-trades

Joshua Brown of Ritholtz Wealth Management named 3M Co. as his final trade on CNBC's Halftime Report, while other experts s...

 medtronic-recalls-some-video-laryngoscopes-due-to-increased-risk-for-battery-overheat-explosion

Medtronic recalls devices over battery risks that could lead to explosions and updates usage instructions.

 fda-says-abbott-diabetes-care-inc-issues-recall-for-certain-freestyle-libre-3-sensors-due-to-risk-for-inaccurate-high-glucose-readings-medtronic-removes-some-mcgrath-mac-video-laryngoscopes-updates-use-instructions-for-others-due-to-increased-risk-for-battery-overheat--explosion

- Reuters

 pacemate-acquires-medtronics-paceart-optima-system-no-financial-terms-disclosed

PaceMate®, a pioneer in cardiac data management and remote monitoring, announced today the acquisition of the Paceart Optima™ s...

 truist-securities-maintains-hold-on-medtronic-raises-price-target-to-90

Truist Securities analyst Richard Newitter maintains Medtronic (NYSE:MDT) with a Hold and raises the price target from $85 t...

 barclays-maintains-overweight-on-medtronic-raises-price-target-to-105

Barclays analyst Matt Miksic maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $104 to $105.

 medtronic-receives-fda-approval-for-expanded-mri-labeling-on-percept-pc-percept-rc-and-activa-pc-rc-sc-devices

- Reuters 

 oppenheimer-maintains-perform-on-medtronic-raises-price-target-to-94

Oppenheimer analyst Steven Lichtman maintains Medtronic (NYSE:MDT) with a Perform and raises the price target from $92 to $94.

 piper-sandler-maintains-neutral-on-medtronic-raises-price-target-to-90

Piper Sandler analyst Matt O'Brien maintains Medtronic (NYSE:MDT) with a Neutral and raises the price target from $85 to...

 rbc-capital-reiterates-sector-perform-on-medtronic-maintains-92-price-target

RBC Capital analyst Shagun Singh reiterates Medtronic (NYSE:MDT) with a Sector Perform and maintains $92 price target.

 wells-fargo-maintains-overweight-on-medtronic-raises-price-target-to-106

Wells Fargo analyst Larry Biegelsen maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $105 t...

 baird-maintains-neutral-on-medtronic-raises-price-target-to-90

Baird analyst David Rescott maintains Medtronic (NYSE:MDT) with a Neutral and raises the price target from $82 to $90.

 stifel-maintains-hold-on-medtronic-raises-price-target-to-87

Stifel analyst Rick Wise maintains Medtronic (NYSE:MDT) with a Hold and raises the price target from $85 to $87.

 wall-street-eases-bonds-rise-us-dollar-falls-to-8-month-low-whats-driving-markets-tuesday

It’s a relatively uneventful session on Wall Street, but with a slightly worsening risk sentiment as all U.S. equity indices tr...

 needham-reiterates-hold-on-medtronic

Needham analyst Mike Matson reiterates Medtronic (NYSE:MDT) with a Hold.

 medical-devices-giant-medtronic-q1-earnings-revenue-and-eps-beat-lifts-annual-guidance-marginally-on-sustained-growth-from-new-product-launches

Medtronic beats Q1 2025 earnings and revenue estimates with $7.9 billion in sales, driven by growth in Cardiac, Neuromodulation...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION